Crowdsourced mapping of unexplored target space of kinase inhibitors
暂无分享,去创建一个
Avner Schlessinger | Tudor I. Oprea | Anna Cichonska | Balaguru Ravikumar | Krister Wennerberg | Tero Aittokallio | Jaewoo Kang | Andrew Lamb | Mariya Popova | Minji Jeon | Sungjoon Park | Olexandr Isayev | Sunkyu Kim | Fangping Wan | Stephen J. Capuzzi | Justin Guinney | David H. Drewry | Jianyang Zeng | Shuya Li | Kristen K. Dang | Stephen J. Capuzzi | Michael J. Mason | Robert J. Allaway | Zia-ur-Rehman Tanoli | Gregory Koytiger | Carrow I. Wells | Timothy M. Willson | Gustavo Stolovitzky | T. Willson | T. Oprea | O. Isayev | T. Aittokallio | Jianyang Zeng | G. Stolovitzky | J. Guinney | A. Schlessinger | Jaewoo Kang | K. Wennerberg | D. Drewry | Andrew Lamb | C. Wells | M. Mason | Minji Jeon | Sunkyu Kim | Fangping Wan | Shuya Li | Ziaurrehman Tanoli | B. Ravikumar | G. Koytiger | Sungjoon Park | A. Cichońska | Mariya Popova | Gregory Koytiger
[1] Tapio Pahikkala,et al. Fast Kronecker Product Kernel Methods via Generalized Vec Trick , 2016, IEEE Transactions on Neural Networks and Learning Systems.
[2] Elina Parri,et al. Drug Target Commons: A Community Effort to Build a Consensus Knowledge Base for Drug-Target Interactions , 2017, Cell chemical biology.
[3] Ming Wen,et al. Deep-Learning-Based Drug-Target Interaction Prediction. , 2017, Journal of proteome research.
[4] Sonya M. Hanson,et al. What Makes a Kinase Promiscuous for Inhibitors? , 2019, Cell chemical biology.
[5] Avner Schlessinger,et al. Multi-targeting Drug Community Challenge. , 2017, Cell chemical biology.
[6] Diogo M. Camacho,et al. Wisdom of crowds for robust gene network inference , 2012, Nature Methods.
[7] John P. Overington,et al. Comprehensive characterization of the Published Kinase Inhibitor Set , 2016, Nature Biotechnology.
[8] Tapio Pahikkala,et al. RLScore: Regularized Least-Squares Learners , 2016, J. Mach. Learn. Res..
[9] Adam A. Margolin,et al. Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas , 2013, Nature Genetics.
[10] R. Couñago,et al. In depth analysis of kinase cross screening data to identify chemical starting points for inhibition of the Nek family of kinases. , 2018, MedChemComm.
[11] A. Hopkins. Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.
[12] Liu Xianming,et al. A Time Petri Net Extended with Price Information , 2007 .
[13] Kohske Takahashi,et al. Welcome to the Tidyverse , 2019, J. Open Source Softw..
[14] Pingzhao Hu,et al. Predicting drug-target interaction network using deep learning model , 2019, Comput. Biol. Chem..
[15] Jens Keilwagen,et al. PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R , 2015, Bioinform..
[16] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[17] S. Friend,et al. Crowdsourcing biomedical research: leveraging communities as innovation engines , 2016, Nature Reviews Genetics.
[18] Mindy I. Davis,et al. Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.
[19] David Rogers,et al. Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..
[20] Bin Li,et al. Applications of machine learning in drug discovery and development , 2019, Nature Reviews Drug Discovery.
[21] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[22] Michael K. Gilson,et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology , 2015, Nucleic Acids Res..
[23] Thomas Yu,et al. Reducing overfitting in challenge-based competitions , 2016, 1607.00091.
[24] Tianqi Chen,et al. XGBoost: A Scalable Tree Boosting System , 2016, KDD.
[25] Tapio Pahikkala,et al. Toward more realistic drug^target interaction predictions , 2014 .
[26] Stephen J. Capuzzi,et al. Progress towards a public chemogenomic set for protein kinases and a call for contributions , 2017, bioRxiv.
[27] Di Wu,et al. DeepAffinity: Interpretable Deep Learning of Compound-Protein Affinity through Unified Recurrent and Convolutional Neural Networks , 2018, bioRxiv.
[28] Gabor T. Marth,et al. SSW Library: An SIMD Smith-Waterman C/C++ Library for Use in Genomic Applications , 2012, PloS one.
[29] Justin Guinney,et al. Alternative models for sharing confidential biomedical data , 2018, Nature Biotechnology.
[30] John P. Overington,et al. The promise and peril of chemical probes. , 2015, Nature chemical biology.
[31] Karsten M. Borgwardt,et al. Prediction of human population responses to toxic compounds by a collaborative competition , 2015, Nature Biotechnology.
[32] Anton Simeonov,et al. Unexplored therapeutic opportunities in the human genome , 2018, Nature Reviews Drug Discovery.
[33] Rajarshi Guha,et al. Pharos: Collating protein information to shed light on the druggable genome , 2016, Nucleic Acids Res..
[34] Aurélien Garivier,et al. On the Complexity of Best-Arm Identification in Multi-Armed Bandit Models , 2014, J. Mach. Learn. Res..
[35] Rajarshi Guha,et al. Chemical Informatics Functionality in R , 2007 .
[36] J. Reymond,et al. Exploring chemical space for drug discovery using the chemical universe database. , 2012, ACS chemical neuroscience.
[37] Krister Wennerberg,et al. The inconvenience of data of convenience: computational research beyond post-mortem analyses , 2017, Nature Methods.
[38] Andrew R. Leach,et al. ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..
[39] Jan Eric Lenssen,et al. Fast Graph Representation Learning with PyTorch Geometric , 2019, ArXiv.
[40] Peter Ertl,et al. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..
[41] Tudor I. Oprea,et al. A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.
[42] Juho Rousu,et al. Computational-experimental approach to drug-target interaction mapping: A case study on kinase inhibitors , 2017, PLoS Comput. Biol..